Most previous studies with specific PKCβ inhibitor ruboxistaurin (LX333531) in vivo and in vitro indicated that PKCβ isoform is primarily responsible for the high-glucose-induced renal effects in diabetes (32–36). This evidence concerns the gene PRKCB and diabetes mellitus.